Insight Holdings Group LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 21.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,170 shares of the semiconductor company’s stock after purchasing an additional 2,670 shares during the period. Synopsys comprises 0.5% of Insight Holdings Group LLC’s investment portfolio, making the stock its 19th biggest position. Insight Holdings Group LLC’s holdings in Synopsys were worth $7,126,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Synopsys in the 4th quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new position in Synopsys in the 4th quarter valued at approximately $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys in the 4th quarter valued at approximately $32,000. Kemnay Advisory Services Inc. purchased a new position in Synopsys in the 4th quarter valued at approximately $35,000. Finally, Oakworth Capital Inc. grew its holdings in Synopsys by 3,700.0% during the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after buying an additional 74 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Price Performance
SNPS stock opened at $461.74 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $88.41 billion, a price-to-earnings ratio of 106.88, a price-to-earnings-growth ratio of 2.63 and a beta of 1.22. The stock’s fifty day simple moving average is $477.08 and its 200-day simple moving average is $461.83. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73.
Analyst Ratings Changes
A number of brokerages have commented on SNPS. Rosenblatt Securities increased their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Piper Sandler increased their target price on Synopsys from $430.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, May 28th. Morgan Stanley increased their target price on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Wells Fargo & Company increased their target price on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Finally, The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Synopsys currently has an average rating of “Hold” and a consensus target price of $563.81.
View Our Latest Stock Analysis on SNPS
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced the first wave of its Multiphysics Fusion solutions, which integrate multiphysics analysis into design workflows and could improve chip design speed, accuracy, and customer adoption. Synopsys Announces Availability of the First Wave of Multiphysics Fusion Solutions
- Positive Sentiment: Synopsys also expanded its ecosystem through a partnership with Murata to provide simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that supports its engineering software platform. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A 247WallSt. commentary said SNPS has been stuck in a weak trading pattern this year, but still projected a year-end price target above current levels, reinforcing a mixed but not bearish long-term view. Synopsys Stock Will End The Year at This Price
- Neutral Sentiment: A DCF-based valuation piece said Synopsys looks fairly valued around $394, suggesting the stock may not be deeply undervalued despite recent weakness. SNPS Fairly Valued by DCF at 394
- Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares and CFO Shelagh Glaser sold 3,394 shares under pre-arranged 10b5-1 plans, which may be routine but can still weigh on investor sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale
- Negative Sentiment: Brokerage coverage continues to show a cautious stance overall, with consensus at “Hold,” which may limit enthusiasm despite solid earnings and revenue growth. Synopsys, Inc. Given Consensus Rating of Hold by Brokerages
Insider Buying and Selling at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
